WESTLAKE VILLAGE, CA–(Marketwire – September 7, 2010) – Compulink Business Systems, Inc., the industry leader in fully customizable electronic health records (EHR) and practice management solutions, announced today it is providing an unrestricted educational grant to the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO®) to develop online courses on EHR for ophthalmic medical personnel.

The online course series allows users to train at their convenience and pace with e-learning technology that transcends the traditional classroom environment and demonstrate their EHR knowledge and performance to qualify for certification. The course is open to two key groups of ophthalmic caregivers: ophthalmologists and ophthalmic allied health personnel, who assist the ophthalmologist in aspects of patient care. In addition, with the comprehensive online course content proposed, the e-learning will be of great interest to the entire eye care team: clinic managers, front office personnel, ophthalmic photographers, ophthalmic nurses, and other members of the eye care team.

“With this significant grant to JCAHPO, Compulink demonstrates its commitment to the ophthalmic community through actions as well as words,” said Link Wilson, President and CEO, Compulink. “We believe it’s critical to help all members of the eye care team learn how to implement, customize and utilize EHR solutions, understand meaningful use and, ultimately, deliver better patient care through the widespread adoption of electronic records.”

The training modules, which are broken into (1) education and training and (2) testing components, encompass the following content categories:

• Electronic Health Records
• Patient Management and Scheduling
• Insurance and Billing
• Financial Management
• Ambulatory Surgical Center
• Systems

Module content also includes such topics as: chart documentation and coding; history and examination; e-Prescribing; disease management; lab orders and results reporting; PQRI data verification; images; patient scheduling and contact management; insurance claims; Medicare; billing and coding; scribing; financial reports; ASCs; and security.

The Compulink grant supports training content and multimedia development, psychometric services for valid assessment, CME and CE applications, pilot testing and project administration expenses.

“EHR is a very important area for training the eye care team in today’s health care environment,” stated William Ehlers, MD, JCAHPO President. “With the government requirements and incentives for transitioning to EHR, it is imperative that all members of the eye care team build their EHR competencies.” 

The JCAHPO is a non-profit organization dedicated to the quality and availability of ophthalmic patient care by promoting the value of qualified allied health personnel and by providing certification and education. 

The program is expected to launch at the American Academy of Ophthalmology (AAO) in Chicago, October 16-19, and will be administered at www.actioned.org, the online training site of the JCAHPO.

About Compulink
With more than 15 years experience in EHR implementation planning, management and technology, Compulink’s fully customizable CCHIT Certified EHR features clinical documentation, exam templates, fully integrated e-Prescribing, and PQRI automation. Backed by an exclusive EHR Success Guarantee and ARRA Certification Guarantee, Compulink also offers unparalleled financing options with its two-year deferred payment plan. For more information, contact Compulink at: [email protected] or 800.456.4522, or visit us at www.compulinkadvantage.com.

About JCAHPO
The Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO®) was established as a not-for-profit organization in 1969 to offer certification and continuing education opportunities to ophthalmic allied health personnel. Since then, more than 25,000 people in the U.S., Canada, and around the world have earned JCAHPO certification. For more information, visit: http://www.jcahpo.org/.

Click here to see all recent news from this company

REDWOOD CITY, CA–(Marketwire – September 7, 2010) – Lunera Lighting, Inc., a Silicon Valley company that designs, manufactures, and markets next-generation LED lighting, is pleased to announce that its award winning, energy efficient LED fixtures are now available for purchase on the General Services Administration (GSA) Schedule. New to the Lunera® team, Harpreet Walia, head of Government Affairs, will be leading the company’s government sales efforts.

The GSA Schedule program provides access to over 11 million commercial products and services at volume discount pricing. To qualify for the GSA Schedule program, all approved vendor products must be compliant with the commercial environment intended.

“We believe in creating sustainable, high quality, digital lighting through a combination of innovative fixture design and state-of-the-art technology. We are delighted that our products were approved on the first round to be included on the GSA schedule. Our commercial LED lighting products enable government agencies to progress towards energy efficient lighting for improved building performance and a more productive work environment,” stated Michael Lesyna, CEO of Lunera Lighting.

Advantages of purchases made through the GSA Schedule:

• Administrative work reduction
• Reduced purchase cycle
• Ease of use
• Procurement control

Lunera products can be purchased and ordered directly by federal customers through the GSA Advantage!® online shopping and ordering system. Products can also be purchased and ordered through Lunera directly. Lunera’s inclusion on the GSA Schedule is enabled through an agreement with Fedlight Supply and can be found through schedule number GS07F-7118B on SIN:206-4.

Lunera’s energy efficient LED fixtures are compliant with the Buy American provisions (Section 1605) of the American Reconstruction and Reinvestment Act of 2009 (ARRA) and the Buy American Act. Lunera’s fixtures are produced and assembled in California and are designed for ARRA-funded public works projects that advance energy efficiency in new construction and building retrofits.

The company is committed to creating products that produce high quality light, following sustainable green building practices, and striving for the greatest level of customer satisfaction. Lunera fixtures help buildings acquire LEED certification, while providing quantifiable energy and maintenance savings leading to a strong return on investment in LED lighting.

Promises Kept vs. Promises Made
The lighting industry is undergoing a disruptive change in technology for the first time in over 100 years. Analysts predict that LED lighting will become the predominant light source within a few years.

Commercial building owners are open to change based on the promise of digital LED technologys: dramatic energy and maintenance savings; reduced environmental impact; and on Lunera’s promise of delivering these benefits while improving the quality of light and fixture design to enhance the space for a building’s occupants. Obtaining accurate information about LED lighting is key to making an educated product choice.

Lunera is committed to providing comprehensive information on LED technology, its environmental benefits plus maintenance and energy savings to help potential customers make an informed purchase decision. Corporate customers interested in making the switch to commercial LED lighting should visit Lunera’s website for more information.

About Lunera Lighting
Lunera Lighting is an award-winning technology innovator leading the transformation from analog to energy-efficient LED lighting. Manufactured in the USA, Lunera’s premium lighting fixtures are particularly attractive when seeking LEED certification, since LED lighting substantially impacts LEED points in “green” buildings. The company is also a firm believer in social and environmental responsibility and has made it part of their corporate philosophy. Visit http://www.lunera.com for more information or contact Lunera at 650-241-3875 or by email at [email protected].

Click here to see all recent news from this company

BETHESDA, MD–(Marketwire – September 3, 2010) – GetWellNetwork, Inc. today introduced a new pediatric Asthma Care Plan for children’s hospitals, available now through GetWell Town™. The Asthma Care Plan helps improve patient outcomes by engaging patients and their families by teaching them to successfully manage the disease at home, leading to fewer hospital stays and emergency department visits. The GetWell Town Asthma Care Plan is immediately available. 

Pediatric asthma is the most common chronic condition among children under 18, affecting more than 6 million children according to the American Lung Association. It has costly effects for both parents and children, costing nearly $719 million in parents’ loss of productivity and asthma related school absences⁽¹⁾. At the same time, it is a condition that can be managed successfully with proper education and care plan. 

“We are truly excited about launching the GetWell Town Asthma Care Plan. The Asthma Care Plan enables care providers to easily involve children and families in a comprehensive educational program that will be instrumental in preparing them to effectively manage their condition at home,” said Sandra Marken, director of nursing pediatrics, Cardon Children’s Medical Center. “We believe that actively engaging children and families in this care plan will result in a decrease of readmissions within 30 days post discharge.”

The new GetWell Town Asthma Care Plan engages parents and children starting at day of admission. It leverages award-winning asthma education videos from KidsHealth^® to educate patients on key concepts that prepare them for managing their condition at home. The Asthma Care Plan introduces information about the disease in four phases:

• Phase One: Patients are introduced to the basics of asthma and begin their in-patient education curriculum.
• Phase Two: Children learn about medications and tools that help manage their condition, and the common triggers to avoid such as second-hand smoke.
• Phase Three: Patients and families are instructed on how to create a safe home environment and taught self-monitoring techniques to recognize signs and symptoms of potential flare-ups; their Care Team also checks-in to monitor their progress through the Asthma Care Plan.
• Phase Four: Patients learn about the take-home Asthma Management Plan and the importance of completing a plan of action before discharge. Patients and family members can also repeat any of the four phases and contact staff members for assistance throughout the learning process.

“The interactive Asthma Care Plan truly allows hospital staff to incorporate condition-specific education throughout the entire care process. By allowing patients and families to progress through the educational plan on their own, they are likely to receive important information at the right time in their hospital stay to better understand their condition and how to manage it,” said Dr. Neil Izenberg, founder and editor-in-chief of KidsHealth. “We are excited that the comprehensiveness of the KidsHealth Asthma Care Suite fits so well into the GetWell Town Asthma Care Plan to create a standardized care plan for young asthma patients.”

“We are honored to work with our GetWellNetwork Children’s Hospital partners and KidsHealth to proactively engage patients and families in managing this condition post hospitalization,” said Shannon O’Neil, director, pediatric product line, GetWellNetwork, Inc. “Further we are confident that young patients who successfully complete the GetWell Town Asthma Care Plan will be better prepared to enjoy active participation in home and school activities.”

About KidsHealth^®

KidsHealth creates engaging online, print, and video media about a wide range of health and family issues in English and Spanish. KidsHealth licenses online content, which can be private-labeled and displayed on a licensee’s website. KidsHealth has a physician-directed, professional editorial staff — and is the largest resource of online children’s health, behavioral, and developmental information written for three distinct audiences: parents, kids, and teens. KidsHealth also creates KidsHealth in the Classroom, a free website for educators featuring standards-based health curricula, activities, handouts, and more. KidsHealth is part of Nemours, one of the nation’s largest nonprofit pediatric health systems. For more information about KidsHealth, please visit www.kidshealth.org/mktg/intro/.

About GetWell Town
GetWell Town was developed in collaboration with GetWellNetwork’s National Children’s Hospital Task Force, comprised of 15 pediatric facilities across the U.S. as well as direct input from pediatric patients and their families. GetWell Town is designed to complement the kid-friendly spaces that children’s hospitals have worked hard to create and features exclusive content in partnership with KidsHealth®, part of The Nemours Foundation’s Center for Children’s Health Media.

About GetWellNetwork
GetWellNetwork, Inc. uses the bedside TV to entertain, educate and empower hospital patients and caregivers to be more actively engaged in their care. This patient-centered approach improves both satisfaction and outcomes for patients and hospitals. GetWellNetwork is the leader in interactive patient care solutions and exclusively endorsed by the American Hospital Association. More information about GetWellNetwork can be found at www.GetWellNetwork.com.

(1) Wang LY, Zhong Y, Wheeler L. “Direct and Indirect Costs of Asthma in School-Age Children.” Preventing Chronic Disease, 2(1): [serial online], January 2005.

Click here to see all recent news from this company

MIAMI, FL–(Marketwire – September 3, 2010) –  Simulated Environment Concepts, Inc. (PINKSHEETS: SMEV), makers of the high pressurized dry water massage and wellness equipment, SpaCapsule, announced today that hot on the heels of the twelve capsule deal with UK-based Aspire Consulting, the SpaCapsule has once again made a splash in international press, courtesy of Ireland’s Life and Fitness Magazine.

Dr. Ella Frenkel, CEO and President of Simulated Environment Concepts, Inc. (SE Concepts), said, “Publicity comes naturally to us. Because of the innovation of our Spa Capsule, we have been featured in numerous TV and print venues — ABC’s Good Morning America, CBS’s Doctors Show, NBC’s Today Show, Rob Report and the New York Times, to name a few. However, it is always a great feeling when you see an unsolicited article about us; especially in a prominent magazine such as Life and Fitness Magazine Ireland.”

Freely distributed nationwide to selected gyms and leisure centers, Life and Fitness Magazine Ireland is one of the country’s leading Health & Fitness Publications covering such topics as weight loss, health, nutrition, wellness, sport and travel.

The featured article, “The Spa Capsule Has Arrived In Ireland” (September 1, 2010), continues to demonstrate the significance of the SpaCapsule and its place in not just the therapeutic markets, but in health and fitness overall. Named “the ultimate wellbeing experience” by Life and Fitness Magazine Ireland, the article continued on to state, “this is an excellent opportunity for those in the wellbeing, massage and sport therapy fields to add to their client offering.”

With distribution deals like that of Aspire Consulting for Vibralife and Zen & O for Lady Fitness, SE Concepts intends to carry on with its expansion into the health and wellness markets, while continuing to cultivate corporate, leisure and therapeutic markets worldwide.

About Simulated Environment Concepts, Inc.

Simulated Environment Concepts, Inc. is the developer of a variety of products for wellness, relaxation, weight loss, and rehabilitation. Our aqua massage and hydromassage products are used by Doctors, Gyms, Spas, retail locations, offices, residential and many other venues. Incorporating oxygen, aromatherapy, massage, and even music or video from an iPod or an iPhone, our products deliver consistent results and excellent earning potential for businesses. For more information on Simulated Environment Concepts and its flagship product, SpaCapsule®, PTjetCapsule™, and Celude Laboratories™ products you can visit the company’s product website at www.spacapsule.com, the corporate website at www.seccorporation.com, or request more information via email at [email protected], or call at (888) 757-0797 or (305) 651-9200.

Safe Harbor

Statements in this news release that are not historical facts, including statements about plans and expectations regarding products and opportunities, demand and acceptance of new or existing products, capital resources and future financial results are forward-looking. Forward-looking statements involve risks and uncertainties which may cause the Company’s actual results in future periods to differ materially from those expressed. These uncertainties and risks include changing consumer preferences, lack of success of new products, loss of the Company’s customers, competition and other factors discussed from time to time in the Company’s filings with the Securities and Exchange Commission.

SpaCapsule is registered trademark of Simulated Environment Concepts, Inc.

Click here to see all recent news from this company

AUSTIN, TX–(Marketwire – September 3, 2010) –  American Physicians Service Group, Inc. (“APS”) (NASDAQ: AMPH) today announced that its Board of Directors had authorized the early redemption of all of APS’ 3% Series A redeemable preferred stock, valued at approximately $6 million, and payment of accrued dividends on the preferred stock through the redemption date.

Mr. Ken Shifrin, Chairman of the Board, said, “This stock was issued in 2007 in payment of refundable surplus deposits provided by our insured doctors three decades ago when our forerunner, American Physicians Insurance Exchange (“APIE”), came into existence. It is very gratifying to satisfy this obligation to those early pioneers who were believers in the doctor-owned insurance concept.”

These distributions will be made on September 24, 2010 to shareholders of record on September 3, 2010.

APS is an insurance services firm with subsidiaries and affiliates which provide medical malpractice insurance and related services for physicians and other healthcare providers. APS is headquartered in Austin, Texas.

This press release includes forward-looking statements related to APS that involve risks and uncertainties that could cause actual results to differ materially. These forward-looking statements are made in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. For further information about these factors that could affect the future results of APS, please see the recent filings with the Securities and Exchange Commission. Prospective investors are cautioned that forward-looking statements are not guarantees of future performance. Actual results may differ materially from management expectations. Copies of the filings are available upon request to APS.

OAK BROOK, IL–(Marketwire – September 2, 2010) –  Virtual Pharma Rep™, a leader in e-detailing marketing strategies, announced today that the company has entered into an agreement to provide their patent-pending e-detailing platform for use as the foundation for a new progressive communication program, in partnership with digitalDVM™, a sales and marketing solutions provider for the animal health industry.

Virtual Pharma Rep™ facilitates a paradigm shift in the traditional sales process, and revolutionizes expensive sales models with a fresh, value-added approach that supplements existing field reps and provides a new voice in the sales process. The partnership between Virtual Pharma Rep™ and digitalDVM™ brings together key components that supplement and enhance existing sales and marketing strategies for the animal health industry. Timely, relevant product and support information will be provided to busy veterinarians in an appealing format that meets the needs of the growing number of practices who prefer online resources that can be accessed at their convenience. 

“Virtual Pharma Rep™ has had significant success in the pharmaceutical industry,” said Jim Rediehs, CEO of Virtual Pharma Rep™. “The versatility of our e-detailing platform allows us to branch into new markets like Animal Health. It shares many similarities with the pharmaceutical market, and VPR provides a tool we know will prove useful for sales reps and veterinarians to maximize time, enhance education and therefore better serve their clients within the animal health industry.”

“More than 80% of physicians participate in e-detailing from pharmaceutical companies, and with the explosive growth of internet use among veterinary professionals, now is the time to make this service available to those in the animal health industry,” said Daryl Schraad, president of digitalDVM™. “virtualVetRep™ complements existing sales and marketing efforts by adding increased voice to top veterinary targets, and provides a cost-effective alternative to increasing field representatives in remote geographical regions.”

digitalDVM™’s virtualVetRep™ offers customized one-on-one virtual sales calls that include streaming video messages, live chat and sample or literature requests. In addition, the service connects veterinarians directly with their field sales representative, which helps optimize field sales call cycles and clinic staff’s time.

The virtualVetRep™ service is available to animal health product manufacturers and distributors worldwide.

About Virtual Pharma Rep™

Virtual Pharma Rep™ is revolutionizing the pharmaceutical industry by leading the paradigm shift to virtual sales support and service models that enhance or replace existing and expensive pharmaceutical marketing strategies. Led by a team that is highly experienced in the creation of future sales and growth strategies in pharmaceuticals, Virtual Pharma Rep™‘s patent pending sales platform shares a cost reduction within the pharmaceutical industry by streamlining existing sales and marketing strategies. In addition, thanks to VPR’s disease awareness, management and compliance processes, VPR assists with overall long-term healthcare cost reductions in the form of fewer doctor’s office visits and hospitalizations. For more information please visit www.virtualpharmarep.com.

About digitalDVM™
With a growing portfolio of advanced technology and innovative marketing platforms, digitalDVM™ enables animal health companies to gain more effective, immediate access to progressive veterinarians. Best-in-class capabilities include virtualVetRep™, an exclusive e-detailing platform for product and service information, groupDVM™ ecommerce solutions, and virtualRepCoach™, the digital alternative for sales representative training and development. Based in Denver with a worldwide clientele, the company works directly with product manufacturers and distributors throughout the animal health industry. More information is available at www.digitaldvm.com.

NEW YORK, NY–(Marketwire – September 2, 2010) –  MedLink (OTCBB: MLKNA), a leading provider of Electronic Health Records and practice management solutions, today announced a partnership with Thrasys, Inc. a provider of next-generation health information technology and solutions. MedLink and Thrasys have collaborated to provide interoperability and health record management based on SyntraNet from Thrasys, a cloud based Health Information Exchange (HIE) and Collaboration Network. SyntraNet enables more efficient and coordinated care across healthcare communities.

“The Agreement with Thrasys strengthens MedLink’s ongoing RHIO community strategy and represents a key milestone in MedLink’s delivery of high-value healthcare solutions on an enterprise level,” said Ray Vuono, President of MedLink. “SyntraNet is a cloud based Health Information Exchange that can be deployed quickly across the service area of RHIOs, providing incredible value as the community scrambles to provide a financially sensible and scalable interoperable solution to meet the ‘meaningful use’ stipulations necessary to receive federal financial incentives to its member physician and healthcare organizations.”

MedLink and Thrasys will market the cloud based HIE platform to Regional Health Information Organizations and Large Hospital groups as a solution for interoperability, and to provide cloud based applications that leverage both MedLink and Thrasys technologies to streamline wide spread EHR adoption.

About Thrasys, Inc.

Thrasys, Inc. based in San Francisco, California brings innovative solutions to the healthcare market based on breakthrough technologies to rapidly build and deploy highly scalable applications targeted at communities and enterprises. Thrasys solutions for healthcare are based on XNet, an open and standards based application platform to rapidly build and deploy enterprise solutions based on XML services, rich internet application user interfaces, configurable workflows and rules, and interoperability. SyntraNet, based on XNet, is a health information exchange and collaboration network that provides a comprehensive set of applications for care providers, patients, service centers and payers. Please visit www.thrasys.com to learn more.

About MedLink

MedLink is a healthcare IT company that provides the medical community with products and services designed to help create, manage, and share medical information. The company’s flagship product, MedLink TotalOffice EHR 3.1, a CCHIT Certified® 08 Ambulatory EHR, provides physicians with full EHR and practice management functionality. For more information regarding MedLink’s products and services, please visit www.medlinkus.com.

Safe Harbor Statement

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, outlined in our 2009 Annual Report on Form 10-K available through www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

SILVER SPRING, MD–(Marketwire – September 2, 2010) –  A new laboratory, designed and built in accordance with international guidelines, opened September 1 in Maseru, Lesotho. The Makoanyane Military Hospital Laboratory now offers an expanded testing menu, including CD4 and Acid Fast Bacilli microscopy, and separate rooms dedicated to specimen reception, microbiology, chemistry, hematology and CD4 testing. The formerly limited, one-room hospital lab was transformed through a collaborative effort of The US Department of Defense and CDC’s Global AIDS Program to support the Lesotho Defense Force’s facility.

The Association of Public Health Laboratories (APHL) provided on-site support and technical assistance to the Lesotho Defense Force, the agency that operates the military hospital, through its cooperative agreement with CDC/GAP in support of PEPFAR.

Senior APHL consultant Kim Lewis worked on-site in Maseru on laboratory design, procurement of equipment and supplies, renovation oversight, organizing laboratory workflow and operations, staff development and initial steps toward WHO Accreditation through implementation of the Strengthening Laboratory Management Towards Accreditation Program. 

APHL will continue to support the new facility by implementing a quality system to assure accurate, reliable and timely test results.

“The laboratory provides access to testing services for a population with high rates of TB and HIV, and enables medical providers to effectively treat these diseases,” said Lewis. “The success of this collaboration is measured in the improved health of the people of Lesotho. The new lab will hopefully affect the well-being of families and lead to a better future for their children. We expect it to serve as a model for other countries.”

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.

Click here to see all recent news from this company

CASCO, ME–(Marketwire – September 2, 2010) –  Camp Sunshine, a one-of-a-kind national retreat in Casco for children with life-threatening illnesses and their families, today announced that Hyundai Hope on Wheels has selected the organization to receive a $100,000 “Hope Grant.” Hope on Wheels is a partnership of 800 Hyundai dealers across the United States and Hyundai Motor America aimed at raising awareness of childhood cancer. Camp Sunshine will use funds from the grant to sponsor two additional oncology sessions at the Camp in 2011.

On Sept. 25 — during National Childhood Cancer Awareness Month — Hope on Wheels will visit Camp Sunshine’s Casco campus and participate in a check presentation ceremony to commemorate the event. Throughout the month, Hope on Wheels will travel to all 68 Hope Grant recipients to present the donations and hear from children, their families and all of those involved in the fight against cancer.

“While we’ve made progress over the last few decades and now have an 85 percent cure rate, cancer still takes more lives than any other childhood disease,” said John Krafcik, President and CEO of Hyundai Motor America. “This September, in support of Childhood Cancer Awareness Month, Hyundai will shine a nationwide spotlight on this cause and provide more than $6 million in grants for pediatric cancer research and support programs. We love taking on big challenges at Hyundai, and we can think of no more worthy challenge than finding a cure for all forms of pediatric cancer.”

Located in Maine’s scenic Sebago Lake region, Camp Sunshine features a 23-acre lakeside campus with private family suites, as well as a climbing wall, indoor swimming pool and computer learning center — all of which are free of charge to all families. To date, Camp Sunshine has welcomed families from 47 states and 17 countries.

“Camp Sunshine is delighted and humbled to receive this generous donation from Hyundai,” said Matt Hoidal, executive director, Camp Sunshine. “This investment will enable us to expand our programs in 2011 and bring nearly 1,000 children and their families much needed respite, support, and hope. We thank Hyundai and their network of dealers in Northern New England and around the country for helping us continue our service and contributions to the cancer community.”

About Camp Sunshine
Camp Sunshine offers children with life-threatening illnesses and their families a place to relax together for a week, and to take a break from the extraordinary demands placed upon them on a daily basis. The year-round program is free of charge and staffed almost entirely by volunteers. It is the only program in the nation whose mission is to address the impact of a life-threatening illness on every member of the immediate family — the ill child, the parents and the siblings. Since its inception in 1984, Camp Sunshine has provided a haven for more than 32,000 individuals from diverse cultural backgrounds. In addition to providing 24-hour on-site medical and psychosocial support, the camp offers a variety of daily activities, including swimming, boating, archery and soccer, and special events such as bonfires and cookouts. To support Camp Sunshine, please call (207) 655-3800 or visit www.campsunshine.org.

About Hyundai Motor America
Hyundai Motor America, headquartered in Fountain Valley, Calif., is a subsidiary of Hyundai Motor Co. of Korea. Hyundai vehicles are distributed throughout the United States by Hyundai Motor America and are sold and serviced through more than 800 dealerships nationwide.

About Hyundai Hope on Wheels
Hyundai Hope on Wheels™ is the united effort of more than 800 Hyundai dealers across the U.S. to raise awareness about childhood cancer and celebrate the lives of children battling the disease. By the end of 2010, Hope on Wheels will have awarded more than $23 million dollars to children’s hospitals and non-profit organizations across the U.S. to support the fight against childhood cancer.

SPRINGFIELD, OH–(Marketwire – September 2, 2010) –  AdCare Health Systems, Inc. (NYSE Amex: ADK), a recognized innovator in senior living and health care facility management, has closed the lease of three nursing homes according to the previously announced agreement to lease five additional nursing homes in Georgia.

The three nursing homes, which have been leased under a 10-year term, have an aggregate of 280 beds that generate approximately $15.5 million in annualized revenue. With the addition of these three facilities and other transactions closed earlier in the year, AdCare’s estimated annualized revenue run-rate now exceeds $79 million, as compared to $26.7 million for the year ended 2009.

Upon closing of the lease transaction, AdCare provided the lessor $195,000 for the first month’s lease payment and a portion of the security deposit, with the balance of $337,000 to be paid over five months comprising the balance of the security deposit and an amount equal to two months lease payments.

“This transaction is the third we’ve closed since we began our M&A campaign at the end of last year,” said Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer. “We expect all of these facilities to be significant cash generators for AdCare, especially as they come under our highly capable management and benefit from our larger economy of scale.”

“As we work toward closing the currently pending transactions we’ve announced, including the lease of the remaining two nursing homes in Georgia, additional opportunities continue to emerge in the southern region of the U.S.,” said Brogdon. “We are working to establish the terms and necessary financings for several new potential acquisitions in our pipeline of equal or greater potential.”

Brogdon joined AdCare last September when the company announced a new M&A growth strategy to build upon its strong reputation for operational efficiency and high-quality living environments.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities, as well as provides home health care services. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
 Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statement can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements that the company expects all of these new facilities to be significant cash generators for AdCare. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management. The forward-looking statements involve known and unknown risks, results, performance or achievements of the Company to differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by the Company with the Securities and Exchange Commission and include the Company’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements.

Click here to see all recent news from this company

LONDON–(Marketwire – September 2, 2010) –  Genome Research Group (GRG) (PINKSHEETS: KKUR) recently announced its intended merger with ChromoCure, Inc. and consolidation of the operations and technologies of both groups. Genome Research Group personnel have assumed all executive and board duties and have no current or planned operations in the USA.

The company intends to open permanent offices in the United Kingdom as well as establish the first of several planned research labs and testing partners.

To date, the Company has not been able to secure its previously anticipated investment capital due to the declining USA economy and capital markets. The Company believes it has now secured satisfactory capital commitments and will proceed with its business plan accordingly.

The Company’s objectives are:

1. Recapitalize the company’s stock structure and change the company’s trading symbol to trade under “Genome Research Group.”

2. Establish business offices and permanent address in the United Kingdom with the most likely location being London.

3. Structure the company’s operations as decentralized management with multiple operational hubs and team members around the world.

4. Secure initial research lab space for the Company’s ongoing research and development for both its cancer imaging systems as well as its therapeutic protocols and animal modeling experiments.

5. Appoint industry leaders to the Company’s Board of Advisors.

6. Partner with cancer labs and pathology labs within the European Union. The Company does not believe the USA healthcare market will be an open market inviting of innovation or new ideas. The Company has no immediate plans to seek partnerships within the USA due to healthcare over-regulation and control by the US government.

7. Complete and deploy company branding, image, and professional design of marketing and educational materials.

8. File updated financial information with appropriate legal opinion letter to achieve “Current” reporting status. The Company has no immediate intent to become a “SEC Reporting” company due to the massive expense and liability of that status.

The Company intends to release updates from time to time as these actions are completed.

About Genome Research Group
Genome Research Group develops and provides proprietary cancer detection systems and related therapeutic technologies. The Company’s proprietary cancer detection system locates and measures unique genomic characteristic found in 100% of all cancers and never found in normal cells. The Company’s proprietary Therapeutic Modeling Protocols provide statistical modeling and prediction tools for the measurement and monitoring of cancer progression and remission. GRG owns proprietary techniques for non-toxic and non-invasive cancer therapy utilizing hypothermic modulation and resonance.

Safe-Harbor Statement
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

DALLAS, TX–(Marketwire – September 2, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) announced today shareholder points of interest discussed during the Company’s nationwide teleconference yesterday. Mr. Bryan A. Scott, President & CEO, and Mr. Brian Hart, COO of Metiscan, provided deeper insight into its subsidiaries’ markets, products, and near term objectives, as well as Metiscan’s pursuit in listing on the OTCBB.

During the Teleconference, Mr. Scott detailed Metiscan’s corporate structure as the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing growing its subsidiary Taptopia through technologies that are unique to its products and through acquisitions that complement its subsidiaries’ operations. Metiscan’s four subsidiaries are FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc. and Shoreline Employment Services, Inc. Mr. Scott further discussed Metiscan’s recent filing of its registration statement and its goal to meet the OTC Market requirements to qualify for the OTCBB market tier.

Mr. Scott also mentioned how Taptopia was founded in July 2009 with the vision of applying new technologies to the $80 Billion convention, trade show and meeting industry that revolutionize the way show managers and event organizers do business. Mr. Scott stated that, “the industry is greatly in need of technologies, more specifically software technologies, that aid exhibitors and attendees to realize more value from their events, as well as aid show managers with tools that help increase attendance and reduce costs.” He also summarized that Taptopia’s goal is to create and roll out new patent protect software technologies, which Taptopia has in its pipeline.

Bryan Hart, COO of Metiscan, mentioned that the Company is trending in a positive manner. Mr. Hart explained how Metiscan realized approximately $2.5M in revenues for year-end 2009, a 144% increase from year-end 2008. During 2010, the Company’s revenues have continued to increase over the last two quarters. Mr. Hart stated, “This quarter alone we experienced a 47% increase in our revenues, or $165,439 from the same period in 2009.” Mr. Hart also mentioned that during the first half of 2010 Metiscan experienced a 16% increase in its revenues, a $194,111 gain. The Company’s overall revenues as of June 30, 2010 were $1,413,490.

Mr. Hart stressed the importance of how digital medical information, specifically the electronic healthcare record systems FirstView administers and Schuylkill Open MRI recently implemented, saves the medical industry time and money. He stated that, “Metiscan strongly believes that storing medical information digitally, and being able to distribute it electronically, is a great cost savings by itself.” Mr. Hart also mentioned that last year $19 billion in the stimulus package targeted physicians to use electronic health record systems because EHR technology cuts costs, eliminates paperwork and helps doctors deliver high quality, coordinated care to patients. Mr. Hart explained that this will benefit Metiscan both for its imaging center as it relates to the benefit of the operational efficiencies EHR provides, and for FirstView as it relates to the professional Healthcare IT services it provides.

Mr. Hart explained how Metiscan demonstrated positive income from operations during the first half of 2010 totaling $184,464. Mr. Hart mentioned that Metiscan has constantly been focused on increasing operational efficiencies in all of its subsidiaries. Mr. Hart gave the example of how Schuylkill Open MRI moved towards more economical service contracts for maintaining all of its MRI equipment in its diagnostic imaging center and recently implemented a new EHR system. With FirstView, Mr. Hart said it reduced costs related to operating its data center and the amount of personnel needed for its billing and collection activities. He summarized his discussion on Metiscan’s subsidiaries, pointing out that Shoreline, its employment services division, has focused on economies of scale as it relates to personnel resources and benefits.

In closing, Mr. Scott stated, “We are very excited about our business activities here at Metiscan. We have great expectations for our company and our team believes in its future. We have been successful in building a company that is displaying both financial growth and innovation in new products and technologies.”

A recording of Metiscan’s nationwide teleconference will be available on the Company’s website at: www.metiscan.com within the next few days.

About Metiscan, Inc.

Metiscan, Inc. (Metiscan) (PINKSHEETS: MTIZ) is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

REDWOOD CITY, CA–(Marketwire – September 1, 2010) – AeroScout, the leading provider of Unified Asset Visibility for the healthcare industry, today announced continued strong growth in its healthcare business, extending its global lead in the healthcare market. 2009 was a record year for AeroScout healthcare revenue, and subsequent to that, the first half of 2010 represented the strongest two quarters in the company’s history for AeroScout’s Healthcare Real-Time Location System (RTLS). In those two quarters, AeroScout received more than 200 orders for its healthcare solutions, which provide real-time visibility into the location, status and condition of assets, patients and staff, from healthcare organizations around the world. One of the main reasons for the rapid adoption is that, with AeroScout’s Wi-Fi RFID solutions, organizations are able to leverage their existing, standard Wi-Fi infrastructures instead of deploying and maintaining separate proprietary networks. 

“In addition to its comprehensive set of Healthcare RTLS solutions and integration capabilities, AeroScout offers hospitals the opportunity to save money while reducing risk and complexity by using their Wi-Fi networks instead of proprietary networks,” said Gregg Malkary, Managing Director of Spyglass. “This means its clients don’t need to purchase, wire and maintain an overlay network, and it has led to rapid growth for AeroScout and Wi-Fi RFID over the past few years.”

Complementing the Wi-Fi advantages, other factors that have contributed to AeroScout’s increasing market leadership include its track record with top hospitals and healthcare systems around the world, its robust suite of solutions, and the ease with which AeroScout solutions integrate with other healthcare information systems, hospital equipment and business processes.

AeroScout has completed implementations at hundreds of healthcare organizations, covering every major region of the world — North America, Australia, Europe, Asia, the Middle East and Latin America. The experience gained over the years from these customers and deployments has continued to increase AeroScout’s healthcare expertise and customer base. Examples of global healthcare customers include:

• Adventist Health System, Winter Park, Florida, USA
• Macquarie University Hospital, Sydney, Australia
• GZA Hospital Group, Antwerp, Belgium
• Akita University Hospital, Akita, Japan
• Hospital Israelita Albert Einstein, São Paulo, Brazil

AeroScout’s comprehensive solutions allow customers to work with a single, proven provider and implement one platform for all current and future asset, patient and staff visibility needs. This includes enterprise-wide asset and people tracking, room-level location, bay-level (sub-room) resolution, optional chokepoint detection, condition monitoring and passive RFID applications.

Focusing on the needs of its global healthcare customers, AeroScout is continuously expanding and enhancing its robust set of healthcare applications, which includes Asset Management, Condition Monitoring, Patient Flow and Patient & Staff Safety. For example, the company recently enhanced its Patient Flow and Patient & Staff Safety solutions by designing and producing the world’s smallest Wi-Fi Tag for patients and staff. AeroScout also supplemented its Condition Monitoring offerings with Humidity Monitoring Solutions, which include Wi-Fi Tags and end-user software.

AeroScout’s range of integrations with healthcare information systems is the broadest in the RTLS market. AeroScout offers integrations with nurse call systems, maintenance management systems, infusion pumps, security and building automation systems, VoIP communication devices and more. For example, AeroScout now integrates with the Rauland-Borg Responder 5 Nurse Call system to enable improved clinician efficiency and workflow. AeroScout also provides MobileView for VoIP Phones, which delivers AeroScout’s end-user software on VoIP communication devices to enhance staff productivity, mobility and communication.

“To serve our multiplying healthcare customer base, we continue to develop and enhance solutions to drive additional value for our clients,” said Yuval Bar-Gil, CEO of AeroScout. “Hospital and healthcare organizations across the globe are using AeroScout’s Wi-Fi-based solutions to reduce capital and operational expenses, increase staff efficiency, facilitate regulatory compliance and improve patient care.”

About AeroScout
AeroScout is the market leader in Unified Asset Visibility solutions. Customers improve operational efficiency using AeroScout products that leverage standard Wi-Fi networks to track and manage the location, condition and status of mobile assets and people. AeroScout’s global customer base consists of leading hospital, manufacturing and logistics organizations, including many of the Fortune 500. The company invented the first Wi-Fi-based Active RFID tag, and today is widely recognized as leading the market in number of deployments and tags shipped. Headquartered in Redwood City, California, AeroScout has offices in Europe, the Middle East, Asia, Australia and Latin America. For more information, please visit www.aeroscout.com.

AeroScout is a registered trademark of AeroScout, Inc. Wi-Fi is a trademark of the Wi-Fi Alliance. All other trademarks are the property of their respective owners. Information is subject to change without notice.

CENTERVILLE, MA–(Marketwire – September 1, 2010) –  UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) announced today that the improved features added to its UV-400 air purifier have been generating a surprising amount of interest from distributors.

The Company recently began coating the inside of its patented UV-400 cartridge with a thin layer of the photo-catalyst Titanium Dioxide (TiO2). Combined with the germicidal UV lamps contained within the cartridge, and moisture in the air, the hydroxyl radicals produced by the TiO2 accelerate the breakdown of molecular bonds present as odors or in the case of Volatile Organic Compounds (“VOC”). These compounds are converted into harmless water vapor and carbon dioxide, which results in significantly reducing the concentration and effects of odors and VOC’s.

“Volatile Organic Compounds, such as acetone, formaldehyde, benzene, as well as hundreds of other compounds, are surprisingly common in offices or households, and can be harmful in even small concentrations to people with respiratory problems, especially children and the elderly,” stated Jack Lennon, President of UV Flu Technologies. “Carpets, building materials, cleaning supplies, paints and varnishes, vinyl floors and furniture, air fresheners, copiers and printers, pesticides, secondhand smoke, wood burning stoves, nail polish remover and hair products; are all just a small sample of the products emitting VOC’s, many of which cause allergic reactions, as well as many of them containing known carcinogens. The UV-400 product has undergone laboratory tests which show the concentration of VOC’s are reduced significantly with each pass, which is repeated several times per hour in a typical room.”

“Many of our customers are very excited about this feature,” commented Bill Fegley, President of Puravair, a major distributor of UV Flu products. “The reduction of the concentration of these compounds and odors is considered very important to a wide array of our customer base, such as salons, health clubs, funeral homes, restaurants and athletic facilities. This feature, combined with the UV-400’s proven ability to kill bacteria, make it a compelling purchase for any location that commonly finds these types of airborne contaminants present in the course of their day-to-day operations.”

Further details regarding the Company’s business, financial reports and agreements are filed as part of the Company’s continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database.

About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality (“IAQ”) industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

ON BEHALF OF THE BOARD

UV Flu Technologies, Inc.
—————————–
John J. Lennon, President & CEO

Click here to see all recent news from this company

DALLAS, TX–(Marketwire – September 1, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) is pleased to announce that the Company will be hosting a Nationwide Teleconference today, Wednesday, September 1, 2010 at 4:15 PM (Eastern Daylight Time) to update the financial community on points of interest that affect Metiscan and its shareholders. The Company will be discussing its recent operational accomplishments that have transpired over the previous six months as well as providing insight into objectives Metiscan has outlined for the near term.

If you would like to participate in the Nationwide Teleconference with Metiscan at 4:15 PM EDT today, please dial 1-800-871-9060, pass code 943301958#.

“This teleconference is very timely for Metiscan; we have accomplished many goals during the last six months that we want to share with the investment community and we look forward to discussing what’s next for the Company in a public forum,” stated Bryan A. Scott, CEO & President of Metiscan, Inc.

The Nationwide Teleconference will be hosted and moderated by Marc Jablon, CEO of Big Apple Consulting USA. The featured speakers for Metiscan, Inc. will be Bryan A. Scott, President, CEO & Director, and Brian Hart, COO.

About Metiscan, Inc.
Metiscan, Inc. (Metiscan), (PINKSHEETS: MTIZ), is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

FOOTHILL RANCH, CA–(Marketwire – September 1, 2010) –  Össur, a global leader in non-invasive orthopaedics, today announced a new strategic alliance with Hely & Weber, a supplier of innovative, high-quality braces and supports. Founded in 1992, founders John Hely and Jim Weber have a combined 76 years of experience in the orthopedic and sports medicine industry. The Hely & Weber line includes renowned products such as the Titan Wrist Brace, Shields Patella Stabilizer, Knapp Hinged Knee, and 24 patented soft bracing products which have a long history of successful clinical performance.

Beginning September 1, Össur will participate in an agreement to distribute Hely & Weber’s line of soft goods through Össur’s Group Purchasing Organization (GPO) contracts. Hely & Weber’s line will also be available through three of Össur’s representatives: Team Makena (So.CA), Synergy Orthopedics (East PA, NJ), and Dashe Orthopedic Supplies (TX, AR, OK).

“We welcome the opportunity to provide Hely & Weber’s high-quality products to our customers,” said Mahesh Mansukhani, Össur Americas president. “The addition of Hely & Weber products to our line expands our ability to provide innovative products that drive successful patient outcomes for our customers.”

John Hely, CEO of Hely & Weber, commented, “We are excited about the opportunity to work with Össur to strengthen our market presence. Össur is a leading company that is well positioned to continue its success in the non-invasive orthopaedic area.”

About Össur

Össur (NASDAQ/OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapies. A recognized “Technology Pioneer,” Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. Össur Americas’ headquarters are based in Orange County, CA.

Click here to see all recent news from this company

LOS ANGELES, CA–(Marketwire – September 1, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrglobal.com) expands its advertising of Personal Health Records products and services (www.mymedicalrecords.com) on national television tonight, September 1, 2010, at 6 pm EDT, in “The Spirit of Mississippi,” on the Hallmark Channel. The Company also announced that starting today, a nationwide radio Listener Loyalty Program was launched with Clear Channel Communications in which listeners will be directed to MMR’s website to take advantage of the Company’s end of Summer Labor Day promotion of a 30-day trial and $25 toward the cost of their next doctor visit (www.mmrvideos.com).

Robert H. Lorsch, Chairman and Chief Executive Officer of MMRGlobal, said, “Labor Day weekend was chosen to launch this radio marketing campaign because it is a great time to reach consumers about the importance of having a Personal Health Record when traveling with the family.”

Lorsch continued, “The people of Mississippi and the entire Gulf region are making progress in rebuilding their lives. Our products offer the reliability and resiliency needed to recover more quickly from any emergency or disaster. With MyMedicalRecords, individuals and families can have direct access to their most important documents, including insurance policies, deeds of trust, wills, birth certificates and advance directives, in addition to their medical records. Everything is located in one secure, convenient location accessible from any Internet connection anywhere in the world.”

About Clear Channel Communications, Inc.

Founded in 1972, with headquarters in San Antonio, TX, the Company broadcasts in over 50 countries through its divisions, Clear Channel Radio: San Antonio, TX and Clear Channel Outdoor: San Antonio, TX and reaches more than 154 million people, or 75% of the 18+ U.S. population, operating over 800 radio stations reaching more than 97 million listeners every week. With international partners, the Company owns and operates more than 140 radio stations in Australia and New Zealand. Premiere Radio Networks syndicates 90 radio programs and services to more than 5,000 radio stations affiliations reaching over 190 million listeners a week.

About MMRGlobal, Inc.

MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements. Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation, television programming changes, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

Click here to see all recent news from this company

EVANSTON, IL–(Marketwire – September 1, 2010) –  Custom health communications company StayWell Custom Communications (SCC), a division of MediMedia USA, has announced that Bob Noel has joined the organization as Vice President of Professional Services.

In his new role, Noel will spearhead the company’s consulting services to help clients achieve best of class implementation of StayWell Custom Communications’ content and cross-media solutions in order to achieve business results.

Noel brings a wealth of professional services experience to the position, including work as
a consultant with more than 100 hospitals and healthcare organizations. He was a co-founder and Executive Vice President of Greystone.Net, Inc., where he provided consulting services to assist clients in the implementation and integration of the Greystone online consumer health information libraries.

Noel’s previous experience also includes working as a Senior Manager in the health care consulting practice of Ernst & Young and as an Assistant Administrator at the University of Alabama in Birmingham Medical Center. He earned a Master’s degree in Healthcare Administration from the University of Alabama in Birmingham. 

“We are extremely pleased to welcome Bob Noel to our team and look forward to the value he’ll bring our clients in their implementation of our solutions,” said StayWell Custom Communications president and CEO Trent Sterling. “With more options than ever for integration of our content across multiple channels and strategies — including SEO, social media, mobile and electronic medical records — it’s increasingly important that our clients undertake a rigorous approach to integration in order to realize the full value of our solutions.”

About StayWell Custom Communications

StayWell Custom Communications is the leader in custom health content solutions delivered via a variety of sophisticated technology platforms. Our interactive offerings include robust web platforms, online health libraries, e-mail and SMS (or mobile) marketing programs, and an extensive range of multimedia tools including video, podcasts and animations. The company serves hundreds of clients representing several channels in the healthcare industry: hospitals and health systems; health plans; employers; and retail organizations. StayWell Custom Communications also offers a comprehensive range of print and print/interactive integrated solutions to meet a broad range of clients’ marketing and communication needs. 

For more information visit www.staywellcustom.com.

About MediMedia

Headquartered in Yardley, PA, with 1,700 employees in offices throughout the U.S., MediMedia changes consumer and professional behaviors through superior engagement, education and end-user preferences. Our health information services group creates, publishes, distributes, and syndicates on and off-line health information to help consumers make informed health decisions on behalf of a variety of sponsors, including providers — both hospitals and physicians, payers, and online media companies. Our health management services group provides population health management services which help consumers lower their health risk, enabling employers to lower their risks, utilization and ultimately their health care expenses. And finally, our professional segment derives its revenues from providing online/off-line professional promotion, engagement, and education services targeted to healthcare professionals and their patients.

MediMedia is a Vestar Capital Partners portfolio company.

SAN DIEGO, CA–(Marketwire – September 1, 2010) –  Recombinant human beta-interferon reduces the frequency of multiple sclerosis (MS) exacerbations and improves MS outcome measures. Unfortunately, current beta-interferon drug products form aggregates that provoke a neutralizing antibody response in MS patients, significantly reducing the effectiveness of the drug.

In a Journal article titled: “n-Dodecyl-?-D-Maltoside Inhibits Aggregation of Human Interferon-?-1b and Reduces Its Immunogenicity” which appeared in the Journal of Neuroimmune Pharmacology, published online on June 7, 2010 scientists from a leading US University Medical School report that addition of a patented ProTek® excipient, a pharmaceutical grade of dodecyl maltoside developed by Aegis, inhibits aggregation and prevents development of antibodies in vivo suggesting a route to greatly improved beta interferon formulations. The abstract of the scientific report may be viewed online at: http://www.springerlink.com/content/v46614510n311211/.

According to Dr. Edward T. Maggio, CEO of Aegis Therapeutics, “Aggregation-induced immunogenicity is a problem for many protein therapeutics, reducing drug effectiveness and in extreme instances, causing life-threatening adverse reactions as with erythropoietin and Factor VIII. And because protein aggregation also adversely affects manufacturing process yields and drug potency it has become a major concern for pharmaceutical formulators worldwide.”

ProTek® excipients are being used to prevent aggregation of monoclonal antibodies, human growth hormone, parathyroid hormone, and insulin, as well as a number of undisclosed proprietary peptide or protein therapeutics now in development.

About Aegis Therapeutics
Aegis Therapeutics commercializes its patented drug delivery and drug formulation technologies through product specific licenses. Our Intravail® technology enables the non-invasive delivery of a broad range of protein, peptide and non-peptide macromolecular therapeutics that can currently only be administered by injection with exceptionally high and unmatched bioavailability. Our ProTek® technology provides proprietary, easily manufacturable, aqueous dosage forms that are stable at elevated temperature and that reduce unwanted immunogenicity of many protein and peptide therapeutics.

SAN CLEMENTE, CA–(Marketwire – August 31, 2010) –  Micro Identification Technologies, Inc. (OTCBB: MMTC) is a California-based public company that has developed, patented and produces a rapid microbial identification (ID) System that revolutionizes the bacteria ID process and can annually save thousands of lives and tens of millions of healthcare dollars. The MIT 1000 System identifies bacteria in minutes, not days, and at significant cost per test savings when compared to any conventional method — it is not reliant on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis — requiring only clean water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually — with food safety accounting for over $3 billion — having expanded at a rate of 9.2 percent annually since 1998. Current growth projections are at 10.2 percent annually reaching $6.2 billion by 2013 and driven by major health, safety and homeland security issues.

MIT, to meet this growing demand, announces today that it has made significant manufacturing progress since its initiation of a manufacturing alliance with OSI Optoelectronics (OSIO), a subsidiary of OSI Systems, to produce the MIT 1000 System. OSIO has manufacturing facilities in California, Malaysia and India. “We are pleased to work with MIT as we feel their innovative product will become a valuable tool to help prevent widespread bacterial contamination in the future,” stated Manoocher Mansouri, OSIO’s President.

“All of OSIO’s world class facilities are ISO 9001:2000 certified, FDA registered and GMP compliant making them the perfect company to fabricate MIT’s systems for food safety applications as well as planned pharmaceutical and clinical diagnostic applications,” stated John Ricardi, MIT’s Executive Vice President and Chief Operating Officer. Mr. Ricardi further added that “While we are predicting quantity deliveries of the MIT 1000 System by the end of this year, initially the systems will be built in OSIO’s California facility, as volume increases, fabrication will move to one of their lower cost overseas facilities enabling MIT to improve future profit margins.” For more information on OSI Systems, visit the company’s website at www.osi-systems.com

The MIT 1000 Systems, in limited production during this last year, have had several distinguished users, including the U.S. Department of Agriculture, Japanese Ministry of Food Safety, University Putra Malaysia and several local contract bioscience testing laboratories. MIT’s Chairman Michael Brennan stated, “We have a small and growing backlog, are in discussions with several potential customers and are on track with this year’s goal to begin quantity deliveries by year’s end, and in turn need to increase our system support and microbiological research capabilities in conjunction with helping improve the food industry’s safety capabilities.”

To fund these activities, MIT has entered into a three-year $5,000,000 equity agreement with the Boston-based private equity firm, Dutchess Capital — the underlying S-1 Registration Statement was recently approved by the Securities Exchange Commission (SEC). MIT’s Chief Executive Officer, Michael Brennan, stated, “We have been very pleased working with Dutchess which has an excellent track record in the investment banking industry and has been a leading provider of private equity for over 10 years. Their successful background was the primary reason we selected them to be one of our partners.”

Chris Quin, Dutchess Vice President of business development stated, “We are excited to work with MIT as they continue to execute their business plan, develop further applications and increase market penetration of their laser-based, rapid microbial identification technology.” For more information on Dutchess Capital, visit the firm’s website at www.dutchesscapital.com

About Micro Identification Technologies:

The MIT 1000 System can identify bacteria in less than five minutes after culturing at a cost of less than 10 cents per test and is a certified AOAC Research Institute (RI) test method of Listeria, one of three bacteria (the others are Salmonella and E.coli) that are responsible for most of the worldwide food contamination events. The Company is in the process of preparing the MIT 1000 System to become AOAC RI certified later this year for the presence of all “three” bacteria with a single mouse click. The AOAC RI Report and Certification are available from the Company. www.aoac.org 

Further, MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, MRSA and other pathogenic bacteria. MIT recently performed over 300 tests for the identification of these contaminants and scored over 95 percent in accuracy. The System’s database currently enables the identification of over twenty species of bacteria and is easily expandable. This identification process has also been verified by North American Science Associates, Inc. (NAMSA), an independent, internationally recognized bioscience testing laboratory. The NAMSA Test Report is available from the Company and, in MIT’s opinion, documents the accuracy, speed and cost effectiveness of the MIT System over conventional processes. www.namsa.com

Please visit our website: www.micro-identification.com

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission, referencing: “MMTC”

NEW YORK, NY–(Marketwire – August 31, 2010) –  On August 31st Fly for MS takes off from New York on a thrilling humanitarian mission to 30 countries in North America, Europe and Asia where the team will fly MS patients for treatment, and share the joy of flying with more than 100 people with MS to raise awareness for the challenges faced by over 2.1 million fighting this debilitating disease.

Fewer than 300 have flown a small plane for such a distance, and none for a humanitarian mission, compared to over 4,000 people who successfully climbed Mount Everest.

The mission will debut with a flight above Manhattan with Tom Clyne of New York, a representative from the U.S. National MS Society suffering from MS.

“Using my cane, I’m reminded of my MS with every step I take. Being up in the air with Andrei and the Fly for MS team, I can be free, even for a few moments. It’s a wonderful and exciting project he’s undertaking to bring awareness to the challenges people with MS experience every day of their lives,” says Tom.

Fly for MS is the brainchild of pilot Andrei Floroiu, a former Wall Street investor focused on biotechnology companies. In his profession he realized from interviews with over 600 MS patients and doctors how little the public knows about MS and recognized the need for a unique event to inspire compassion and action.

MS patients face harsh realities including lack of services due to budget cuts and limited availability of proper treatment. Ignorance of MS often forces people with MS to withdraw from society, hiding an illness poorly understood.

MS is a debilitating disease that affects 1.5 million people in North America and Europe alone. The symptoms of MS are cruel and include paralysis, speech impairment, and blindness. MS typically strikes people between the ages of 20 – 50 and renders 60% of those touched disabled over time. MS also affects an estimated 50,000 children globally.

With no known cause or cure in sight, awareness will move MS higher on government agendas, change employers’ attitudes and educate the world how to help. Awareness has a multiplier effect on future research funding.

“Through this unprecedented journey we aim to expose the contrast between the ultimate freedom of flying and the limitations of those living with MS, and reach new, broader audiences that other efforts have not been able to in the past,” says Floroiu.

“As a volunteer driven organization, it is bold, imaginative and independent projects such as Fly for MS that raise awareness for the challenges of living with MS and the funds needed to move us closer to a world free of the disease. The Society certainly encourages this heart-felt endeavor,” says Joyce Nelson, President and CEO of the U.S. National MS Society.

On certain legs of the tour, MS specialists, advocates, public figures and journalists will fly along.

Competitions are organized in certain countries for those that want a flight in the Fly for MS plane and the team will join fundraisers and awareness events across Europe.

Updates and photographs from the mission will be posted daily at www.flyms.org, Twitter, and Facebook. For more information visit: http://www.flyms.org/fly-for-multiple-sclerosis-schedule.html

Click here to see all recent news from this company

DALLAS, TX–(Marketwire – August 31, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) is pleased to announce that the Company will be hosting a nationwide teleconference on Wednesday, September 1, 2010 at 4:15 PM (Eastern Daylight Time) and will discuss points of interest that affect Metiscan and its shareholders. The Company will be discussing its recent operational accomplishments that have transpired over the previous six months as well as providing insight into objectives Metiscan has outlined for the near term.

The nationwide teleconference will be hosted and moderated by Marc Jablon, CEO of Big Apple Consulting USA. The featured speakers for Metiscan will be Bryan Scott, President, CEO & Director, Janine Frieh, CFO & Director, and Brian Hart, COO & Director.

Space is limited on the call-in lines, therefore in order to participate please call 407-389-5900 and ask for investor relations to make a reservation. If you have a particular question for Mr. Scott, Ms. Frieh or Mr. Hart, please email questions in advance to [email protected].

About Metiscan, Inc.

Metiscan, Inc. (Metiscan), (PINKSHEETS: MTIZ), is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

NATICK, MA–(Marketwire – August 31, 2010) –  Interbit Data, a leading provider of software and services for improving healthcare efficiency, today announced it has been named to Inc. Magazine‘s exclusive list of the 5,000 fastest growing private companies in the United States for the second year in a row. The company ranked No. 1902 as a result of achieving over 142% growth from 2006 to 2009, a significant move up from its ranking of No. 2909 on the 2009 Inc. 5000 list. This growth places Interbit Data at No. 152 in the health industry ranking and No. 64 among Boston, MA area companies.

“Our continued growth during this economy is not only proof of our staying power, it is confirmation of the significant value our software delivers in terms of time and cost savings,” said Arthur Young, president of Interbit Data. “We are dedicated to helping healthcare providers improve the level of care by addressing their challenges with streamlining operations, distributing patient data and reports, and ensuring access to critical patient records during system downtimes.”

Since 1997, Interbit Data has sold its software solutions for improving operational efficiency to over 650 healthcare providers and organizations in the U.S., Canada and U.K. The company offers three types of solutions that contribute to increased productivity, reduced costs, and, ultimately, better and more consistent patient care:

• Information distribution — automates the secure transfer of information over the Internet in multiple formats (print, fax, email or file), easily integrating it into physician practices’ electronic medical records (EMRs) using the industry standard HL7 format.
• Business continuance — ensures up-to-date patient data is readily available in the event of a network or system outage.
• Scheduling and workforce automation — automates manual scheduling, enabling organizations to easily implement a complex schedule and efficiently manage staff.

The 2010 Inc. 5000 serves as a unique illustration of the profound changes taking place in the U.S. economy. Despite the fact that most of this year’s measuring period of 2006-2009 took place during the latest recession, aggregate revenue among the companies on the list actually increased to $321.6 billion, up more than 50 percent from last year. The effects of the recession are seen, however, in the median three-year growth rate, which dropped to 96 percent from last year’s 126 percent.

This year’s Inc. 5000 employ a record 1.4 million people, up from one million on last year’s list. The Health sector is the top employer with 287,726 jobs, followed by Business Products & Services (230,066), Food & Beverage (108,344), Human Resources (107,924), and Retail (96,858).

The top five industries by total revenue are Business Products & Services ($84.7 billion), Health ($48.3 billion), Consumer Products & Services ($26.4 billion), Retail ($22.3 billion), and Government Services ($15.1 billion).

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found on www.inc.com/5000.

Inc. 5000 Methodology
The 2010 Inc. 5000 is ranked according to percentage revenue growth when comparing 2006 to 2009. To qualify, companies must have been founded and generating revenue by June 30, 2006. Additionally, they had to be based in the United States, privately held, for profit, and independent — not subsidiaries or divisions of other companies — as of December 31, 2009. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2006 is $80,000; the minimum for 2009 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. The top 10 percent of companies on the list constitute the Inc. 500, now in its 29th year.

About Inc. Magazine
Founded in 1979 and acquired in 2005 by Mansueto Ventures LLC, Inc. (www.inc.com) is the only major business magazine dedicated exclusively to owners and managers of growing private companies that delivers real solutions for today’s innovative company builders. With a total paid circulation of 712,647, Inc. provides hands-on tools and market-tested strategies for managing people, finances, sales, marketing, and technology. Visit us online at Inc.com.

About Interbit Data
For more information about Interbit Data and its NetSolutions healthcare IT products, visit the company Website at www.interbitdata.com.

Click here to see all recent news from this company

KANKAKEE, IL–(Marketwire – August 31, 2010) –  Riverside Medical Center, whose mission is to meet the health and well-being needs of the communities it serves, provided more than $36.7 million in community benefit in 2009. This high quality southern Chicago suburbs healthcare provider receives no payment for a wide variety of vital programs and services devoted to individuals and families through the medical center’s service area. As one of the top hospitals in Illinois, Riverside is committed to making quality healthcare available to everyone, regardless of their economic condition. 

The income, employment and insurance status of residents of Kankakee County results in the hospital caring for a large number of patients who are uninsured or underinsured, or for whom public program reimbursement is inadequate to cover costs. Of the $36.7 million of community benefit that Riverside Medical Center provided in 2009, over $18.1 million of the total covered costs was for subsidized health services. That included Medicaid services and community health centers in Kankakee, Momence and Hopkins Park. This figure also includes New Life Center, ambulance services, health screenings, physician recruitment and health care education, among other services.

As a nonprofit organization, after paying expenses, Riverside reinvests any excess revenue back in the organization to pay for capital improvements. Riverside also allocates portion of this money to services that benefit patients: free care for patients who cannot pay, subsidized care for patients whose government insurance does not cover all of Riverside’s costs, and critical medical services that operate at a financial loss but are necessary for the overall health and well-being of the community.

Riverside also acts as an economic engine for Kankakee County and the surrounding areas like southern Will County healthcare. Not only do they provide care for those who are not financially able to afford it, but they also help create more jobs and economic growth in our community. Riverside not only has a significant impact on the health and welfare of residents, but also has a large impact on the local economy, both of which are definitely for the better. If you are in need of any sort of medical services, Riverside Medical Center is here to make sure you get the best care provided anywhere.

To learn more about the quality services offered by Riverside Medical Center, visit www.RiversideMC.net or call (815) 933-1671.

Click here to see all recent news from this company

RALEIGH, NC–(Marketwire – August 31, 2010) – Healthcare experts got a dose of Lean Six Sigma principles when Rucker and Associates presented its best industry practices to ISH, Inc. to help them better understand the power of Lean Six Sigma for efficiency and productivity. Florida-based ISH, Inc. has developed hundreds of quality improvement initiatives at many of the nation’s leading healthcare organizations. Working with Rucker has been their first exposure to Lean Six Sigma principles in action.

ISH, Inc. is a leading provider of office processing and time management software for the healthcare industry. Bonnie Smith of Rucker and Associates handled the presentation to administrators at ISH, Inc., providing them with information on ways to integrate Lean Six Sigma principles into everyday operations to improve performance. 

According to Smith, the strategy at ISH, Inc. focused on lead-time to reduce defects and improve the company’s workflow. “Finding ways to improve what we refer to as ‘profit-busters’ will not only decrease waiting times and improve patient care but save a healthcare organization money,” she said.

Smith’s seven profit-busters that plague the industry include: waiting, over-processing, over-production, indecision, hand-offs, loop-backs and excess inventory.

She uses Rucker case examples to explain: “Hospitals that use Lean Six Sigma have saved $16 million through efficiency improvements that include: reducing emergency room wait times by one hour, reducing turnaround times for patient tests from 74 to 40 minutes, lowering in-patient registration questions from 39 to six, and more timely accounts receivables,” she said.

“Controlling these efficiencies helps healthcare organizations save valuable time and resources, which impacts the bottom line,” said Smith, an efficiency expert who played a pivotal role in creating the synthesis of Lean principles and Six Sigma tools now known as Lean Six Sigma.

Healthcare organizations are more actively using Lean processes to improve clinical trials and supply chain management. According to Rucker statistics, Lean Six Sigma has helped hundreds of healthcare organizations improve quality measures and increase bottom line profitability.

Rucker and Associates is a high-performance consultancy dedicated to helping companies discover dramatic new efficiencies using Lean Manufacturing and Six Sigma improvement methodologies. Rucker’s hands-on mentoring process with clients produces dramatic results — training teams to accelerate change and implement continuous improvement. Every Rucker project features an unconditional guarantee. http://ruckerassociates.com/.

Headquartered in Fairfield, N.J., ISH, Inc. is a leading national provider of professional services for healthcare, including: Perioperative, Sterile Processing, ED, EMR, Supply Chain, Finance, HR/PR, Time and Attendance, Scheduling, Document Imaging, Interim Management. ISH has delivered business improvement solutions and information technology implementations to prominent healthcare providers throughout the nation since 1989. With a staff of more than 150 professionals, an extensive best practice library developed from over 500 clients, and a powerful program management methodology, ISH is positioned to deliver the results you need when you need them. http://www.ishinc.com.

Click here to see all recent news from this company